Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach

K. Kahnert (München, Germany), P. Alter (Marburg, Germany), T. Welte (Hannover, Germany), R. Huber (München, Germany), J. Behr (München, Germany), F. Biertz (Hannover, Germany), H. Watz (Grosshansdorf, Germany), R. Bals (Homburg, Germany), C. Vogelmeier (Marburg, Germany), R. Jörres (München, Germany)

Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Kahnert (München, Germany), P. Alter (Marburg, Germany), T. Welte (Hannover, Germany), R. Huber (München, Germany), J. Behr (München, Germany), F. Biertz (Hannover, Germany), H. Watz (Grosshansdorf, Germany), R. Bals (Homburg, Germany), C. Vogelmeier (Marburg, Germany), R. Jörres (München, Germany). Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach. 1178

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: